-
EDITORIAL
2018 Parenteral outlook
R. M. Johnson
-
LASTEST NEWS
Potential effects of Brexit on the healthcare, pharma and public procurement
P. Parkin
-
COLUMN: INTELLECTUAL PROPERTY
The unified patent court and the opt-out mechanism
G. Tagliafico, S. Venturini
-
COLUMN: COMPLIANCE
New law introduces broader protection for Italian “whistleblowing” workers
G. Campalani, A. R. Pometto
-
PANEL DISCUSSION: PARENTERAL DRUG MANUFACTURING
-
LITERATURE NEWS – PARENTAL DRUGS
-
CONTRACT MANUFACTURING
Highly potent molecules: why safe and effective processing is critical
D. O' Connell
-
CONTRACT MANUFACTURING
Legal challenges with Indian One-Stop-Shop pharmaceutical CMO – You say ‘tomato’ I say ‘tomatoes’, still sliced the same!
R. Balani
-
COLUMN: MARKETPLACE
Pharma M&A deals in 2017, and what we can expect for the near-term future
C. Bieri
-
COLUMN: MARKETPLACE
Preparing for the effects of Brexit on science and innovation
L. Van Der Meer
-
COLUMN: MERGERS AND ACQUISITIONS
Keep exits clear, plans aligned to take advantage of M&A opportunities
J. Boggs
-
ANALYTICAL TESTING
Finished prefilled syringes integrity testing Method development, validation and 100% in-line high speed solution
G. B. Golinelli
-
SCIENCE PIONEERS
Rachel Fuller Brown and the invention of Nystatin
M. Milano
-
INDUSTRY 4.0
Industry 4.0 and Smart factory – A new challenge for people
G. Grosso
-
BUSINESS NEWS